Insider · CIK 0001786966

Edris Badreddin

Reports to the SEC for 2 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001786966

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,188 sh	—	—	8,188
2026-06-05	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,619 sh	—	—	5,619
2026-01-21	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	0
2026-01-21	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,605 sh	—	—	0
2026-01-21	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−66.5K sh	—	—	0
2026-01-21	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.5K sh	—	—	0
2026-01-21	EWTXEdgewise Therapeutics, Inc.S Sale	Director	SSale	−66.5K sh	$29.44	−$1.96M	19,820
2026-01-21	EWTXEdgewise Therapeutics, Inc.S Sale	Director	SSale	−10.5K sh	$29.44	−$308K	86,297
2026-01-21	EWTXEdgewise Therapeutics, Inc.S Sale	Director	SSale	−7,605 sh	$29.44	−$224K	96,760
2026-01-21	EWTXEdgewise Therapeutics, Inc.S Sale	Director	SSale	−17.2K sh	$29.44	−$507K	104,365
2026-01-21	EWTXEdgewise Therapeutics, Inc.S Sale	Director	SSale	−13.7K sh	$29.44	−$403K	121,601
2026-01-21	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,605 sh	$0.71	+$5,399.55	135,291
2026-01-21	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+66.5K sh	$1.93	+$128K	127,686
2026-01-21	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	$1.93	+$20.2K	61,209
2026-01-21	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$0.64	+$11K	50,746
2026-01-21	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.7K sh	$0.39	+$5,339.1	33,510
2026-01-21	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.7K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−120K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Performance Share UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−33.8K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−3,868 sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−149K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−100K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−240K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−79K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−170K sh	—	—	0
2025-06-16	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−12.1K sh	$54.26	−$655K	173,710
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,924 sh	$53.12	−$208K	185,788
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,598 sh	$55.12	−$198K	170,112
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−400 sh	$56.20	−$22.5K	169,712
2025-02-10	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−30K sh	$53.13	−$1.59M	189,712
2025-01-10	SpringWorks Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+27K sh	—	—	219,712
2025-01-10	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+79K sh	—	—	78,960
2025-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−4,416 sh	$38.86	−$172K	192,689
2025-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−5,561 sh	$38.19	−$212K	197,105
2025-01-04	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−6,934 sh	$38.19	−$265K	202,666
2024-12-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−12K sh	$41.78	−$500K	217,634
2024-12-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−8,034 sh	$42.24	−$339K	209,600
2024-09-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−4,620 sh	$41.12	−$190K	232,680
2024-09-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,080 sh	$42.08	−$130K	229,600
2024-09-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−12.3K sh	$40.11	−$493K	237,300
2024-06-10	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.6K sh	—	—	20,594
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−11.8K sh	$39.40	−$464K	257,828
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−4,192 sh	$40.62	−$170K	253,636
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−385 sh	$42.04	−$16.2K	249,600
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,651 sh	$41.38	−$151K	249,985
2024-01-08	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−5,466 sh	$41.53	−$227K	269,600
2024-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−4,469 sh	$37.96	−$170K	275,066
2024-01-04	SpringWorks Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+42.3K sh	—	—	279,535
2024-01-04	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+120K sh	—	—	120,000

Recent filings

Accepted (ET)
Jun 164
Edris Badreddin0001786966-26-000003
SEC(opens sec.gov)
Jan 234
Edris Badreddin0001786966-26-000001
SEC(opens sec.gov)
Jul 24
Edris Badreddin0001104659-25-065322
SEC(opens sec.gov)

Companies

Address

C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET

BOULDER, CO, 80301